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In response to oncogenic insults, normal human cells execute a defense response that culminates in cellular suicide, apoptosis. Normal
human diploid fibroblasts expressing the human papillomavirus type 16 (HPV-16) E7 oncoprotein are predisposed to apoptosis when they are
deprived of growth factors. Even though a dominant negative p53 mutant abrogates the cell death response, it is not accompanied by p53
phosphorylation, the DNA binding capacity of p53 remains unaltered, and no activation of common p53-dependent transcriptional targets is
observed. Expression of two insulin-like growth factor-1 binding proteins, IGFBP-2 and -5, is increased presumably in response to enhanced
NF-nB activity in HPV-16 E7-expressing serum-starved cells. Phosphorylation of AKT, an important modulator of IGF-1 survival signaling,
is lower in serum-starved E7-expressing cells, and exogenously added IGF-1 can partially inhibit the cell death response. This suggests that
IGFBP-2 and -5 may limit IGF-1 availability thus decreasing survival signaling. Caspase 3 but not caspase 8 is activated in serum-starved
HPV-16 E7-expressing cells. Caspase inhibition affects nuclear DNA fragmentation, but cell death is not inhibited. Although mitochondria
play important roles in caspase-dependent as well as -independent forms of cell death, there is no evidence for cytochrome c release and thus
for mitochondrial permeabilization in growth factor deprived HPV-16 E7-expressing cells.
D 2003 Elsevier Inc. All rights reserved.Keywords: Trophic sentinel; HPV-16; Fibroblast; E7, apoptosisIntroduction
Studies with the adenovirus E1A and c-myc oncoproteins
revealed that normal cells expressing single nuclear onco-
genes are predisposed to apoptosis particularly when grown
under conditions of growth factor deprivation (Evan et al.,
1992; White et al., 1991). This ‘‘trophic sentinel pathway’’
represents a cellular defense mechanism to eliminate rene-
gade cells that harbor the potential for neoplastic transfor-
mation (Evan and Vousden, 2001). Subversion of this0042-6822/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
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Mahidol University, Bangkok 10400, Thailand.apoptotic response constitutes an important aspect of the
concept of oncogene cooperation (Fanidi et al., 1992;
Pelengaris et al., 2002; White et al., 1984) and is of
fundamental importance for carcinogenic progression
(reviewed in Hanahan and Weinberg, 2000).
High-risk human papillomaviruses (HPVs) account for
the vast majority of cervical cancers, a leading cause of
cancer death in young women worldwide (reviewed in zur
Hausen, 2002). Because of the frequent integration of the
HPV genome into a host cellular chromosome during ma-
lignant progression, only two viral genes, namely E6 and E7,
remain expressed in the tumors. E6 and E7 each have
oncogenic activities in tissue culture and transgenic animal
models and encode small proteins of approximately 160 and
100 amino acid residues, respectively. These proteins have
no known enzymatic activities and function by targeting
various host cell regulatory pathways through protein–
protein interactions (reviewed in Munger, 2002). Most
notably, the high-risk HPV E7 proteins inactivate the reti-
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pocket proteins p107 and p130 by proteasome-mediated
degradation (Boyer et al., 1996; Gonzalez et al., 2001).
The cooperating high-risk HPV E6 proteins target the p53
tumor suppressor protein for degradation (Scheffner et al.,
1990) through interaction with the ubiquitin ligase E6AP
(Scheffner et al., 1993).
Earlier studies have revealed that expression of the
HPV-16 E7 oncoprotein predisposes normal human diploid
IMR-90 fibroblasts to apoptosis upon growth factor with-
drawal. These cells constitute a homogenous cell popula-
tion that contains wild-type p53 and pRb tumor suppressor
functions, have a limited proliferative life span, and readily
undergo growth arrest upon growth factor deprivation.
Hence, they are a convenient model system to analyze
HPV oncoprotein activities in the context of a normal
human cell. The pro-apoptotic activity of HPV-16 E7 in
serum-deprived IMR-90 cells correlates with its ability to
induce pRb degradation and p53 stabilization and is
abrogated by co-expression of HPV-16 E6 (Jones et al.,
1997). It has been postulated that the frequent combined
abrogation of the p53 and pRb pathways in human tumors
may reflect the necessity of subverting the p53-mediated
apoptotic response to offset aberrant cell proliferation as a
consequence of pRb pathway inactivation (reviewed in
Hanahan and Weinberg, 2000).
The levels of p53 are increased in HPV-16 E7-express-
ing cells (Demers et al., 1994) because of protein stabi-
lization (Jones et al., 1997). Mutational analyses showed
that the ability of HPV-16 E7 to induce p53 stabilization
correlated with pRb degradation (Jones et al., 1997) but
additional studies revealed that HPV-16 E7 could stabilize
p53 independent of p19ARF, an E2F-regulated inhibitor of
mdm2-mediated p53 degradation (Seavey et al., 1999).
Stabilization of p53 is generally accompanied by a con-
comitant induction of transcriptional activity. Intriguingly,
however, the stabilized p53 in HPV E7-expressing cells
remains transcriptionally inert in that no increases in the
transcription of a variety of known transcriptional targets
of p53 were detected (Eichten et al., 2002; Jones et al.,
1999).
On the basis of these studies, we analyzed the trophic
sentinel response to serum deprivation of HPV-16 E7-
expressing normal diploid human cells. Expression of a
dominant-negative p53 mutant abrogated HPV-16 E7-me-
diated apoptosis, suggesting that p53 function is necessary
for engaging the trophic sentinel response. Expression
analysis of p53 responsive genes revealed that p53 is not
activated as a transcription factor in HPV-16 E7-expressing
apoptotic cells. Moreover, the phosphorylation status and
DNA binding capacity of p53 is not noticeably altered in
HPV-16 E7-expressing cells when they are deprived of
growth factors. We discovered increased expression of two
IGF-binding proteins, IGFBP-2 and IGFBP-5, in HPV-16
E7-expressing cells, and their expression was further
enhanced upon serum deprivation. The higher level ex-pression of these two proteins in HPV-16 E7-expressing
cells is likely NF-nB mediated, which is activated in HPV-
16 E7-expressing cells undergoing serum starvation. Serum
deprivation of HPV-16 E7-expressing cells was accompa-
nied by dephosphorylation of AKT, an important modula-
tor of IGF-1-mediated cellular survival signaling.
Exogenously added IGF-1 partially inhibited the cell death
response in serum-starved HPV-16 E7-expressing cells.
Caspase 3 but not caspase 8 was activated in HPV-16
E7-expressing cells undergoing apoptosis. Caspase inhibi-
tion abrogated nuclear DNA fragmentation but did not
block cell death. Hence, caspase-independent mechanisms
contribute to the cytotoxic response to HPV-16 E7 expres-
sion in growth factor deprived cells. No evidence for
caspase 2 activation and cytochrome c release from the
mitochondria was detected, indicating that HPV-16 E7-
mediated apoptosis may not be signaled through mitochon-
drial dysfunction.Results
The ‘‘trophic sentinel’’ response in HPV-16 E7-expressing
cells is p53 dependent
It was shown previously that the co-expression of HPV-
16 E6 abolished apoptosis of HPV-16 E7-expressing cells
upon growth factor withdrawal (Jones et al., 1997). Since
in addition to p53, the HPV E6 proteins target several
other signal transduction pathways that might be involved
in modulating the trophic sentinel response (reviewed in
Munger and Howley, 2002), we explored whether p53
inactivation through a different mechanism might also
inhibit HPV-16 E7-mediated apoptosis in response to
growth factor deprivation. Stable HPV-16 E7-expressing
IMR-90 cell lines were generated, co-expressing either a
carboxyl terminal fragment of p53 (p53DD) or HPV-16 E6
as a positive control. The p53DD mutant lacks the trans-
activation domain, interacts with wild-type p53, and forms
metabolically stabilized transcriptionally inert heterote-
tramers (Gottlieb et al., 1994). The different IMR-90 cell
populations were grown in the presence and absence of
fetal bovine serum (FBS), and apoptosis was determined
by two independent methods. Nuclear condensation was
monitored by fluorescence microscopy of Hoechst 33258
stained nuclei, and chromosomal DNA degradation into
nucleosomal fragments was analyzed by a quantitative
ELISA-based DNA laddering assay. The apoptosis rates
upon growth factor deprivation of HPV-16 E6 or p53DD
expressing cells were similar to control cells. As expected,
HPV-16 E7-expressing populations exhibited elevated lev-
els of apoptosis upon serum deprivation, and this response
was abrogated when HPV-16 E6 was co-expressed (Jones
et al., 1997) (Fig. 1A). Similarly, expression of the
dominant negative p53DD mutant abrogated the apoptotic
response to serum deprivation of HPV-16 E7-expressing
Fig. 1. (A) The trophic sentinel response in HPV E7-expressing cells induced by serum starvation is p53 dependent. Induction of apoptosis in the different cell
lines as determined by fluorescence microscopic analysis of nuclear abnormalities (left panel) and nucleosomal DNA fragmentation using an ELISA-based
quantitative DNA laddering assay (right panel). The values shown were calculated by determining the relative increases of apoptosis and DNA fragmentation,
respectively, for each cell population in the absence or presence of fetal bovine serum for 48 h derived from a single experiment. Similar results were obtained
in multiple independent experiments. (B) Immunoblot analysis of the steady state levels of p53, p21CIP1, and HPV-16 E7 in the different cell populations in
response to DNA damage induced by actinomycin D (actD) treatment. GAPDH expression is shown as a loading control. See Materials and methods for
details. (C) Analysis of p53 phosphorylation by immunoblot analysis with various phospho-specific antibodies in control (LXSN) and HPV-16 E7-expressing
(E7) IMR-90 cells in the absence (0%) or presence (10%) of fetal bovine serum (FBS). UV-irradiated cos7 and control (LXSN) and HPV-16 E7-expressing (E7)
IMR-90 cells were used as positive controls. GAPDH expression is shown to document equal loading. (D) DNA binding capacity of p53 in control (LXSN) and
HPV-16 E7-expressing (E7) IMR-90 cells grown in the absence (0%) or presence (10%) of fetal bovine serum (FBS) by EMSA. Wild-type or mutant
oligonucleotide competitors or a p53-specific antibody were added to demonstrate the specificity of the shifted band; ns denotes a nonspecific band. Lysates
from the human Raji cell line were supplied as a positive control by the manufacturer of the kit (GENEKA).
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16 E7-mediated apoptosis upon growth factor deprivation
is dependent on p53.
To ensure that expression of HPV-16 E6 or p53DD
causes the predicted transcriptional inactivation of p53, the
different cell populations were exposed to the DNA
damaging agent actinomycin D that induces growth arrest
through p53-mediated induction of p21CIP1. Expression of
p53 and its transcriptional target p21CIP1 were assessed by
immunoblot analysis. In agreement with previous studies,
levels of p53 and p21CIP1 were increased in HPV-16 E7-
expressing cells presumably because of protein stabiliza-
tion (Jones et al., 1999). Treatment of control and HPV-16
E7-expressing IMR-90 populations resulted in increased
levels of p53 and its transcriptional target p21CIP1, consis-
tent with p53 activation in response to DNA damage. Cells
expressing p53DD alone or in combination with HPV-16
E7 also contained increased p53 levels because of complex
formation with the p53DD mutant. Steady state levels of
p53 and p21CIP1, levels, however were unaltered uponactinomycin D treatment, consistent with inactivation of
p53 (Fig. 1B).
p53 is not differentially phosphorylated in apoptotic versus
proliferating HPV-16 E7-expressing cells
Phosphorylation changes have been implicated in sta-
bilization and transcriptional activation of p53 (reviewed
in Stewart and Pietenpol, 2001). We have previously
shown by two-dimensional gel electrophoresis that there
are no dramatic alterations in the phosphorylation pattern
of p53 in normal and HPV-16 E7-expressing IMR-90
cells (Eichten et al., 2002). To determine whether p53 in
HPV-16 E7-expressing cells is differentially phosphorylat-
ed upon growth factor withdrawal, the phosphorylation
status of known serine residues was determined by
immunoblot analyses using phospho-specific antibodies.
UV treated COS-7 as well as control and E7-expressing
IMR-90 cells were used as controls for the phospho-
specific antibodies. No increases in p53 phosphorylation
A. Eichten et al. / Virolog84at serine residues 6, 9, 15, 20, 37, or 46 were observed in
serum-deprived HPV-16 E7-expressing cells (Fig. 1C).
Furthermore, these results illustrate that p53 levels in
HPV-16 E7-expressing cells do not change upon serum
starvation.
The DNA binding activity of p53 in HPV-16 E7-expressing
cells is not enhanced upon growth factor withdrawal
Since inhibition of p53 activity abrogates apoptosis in
HPV-16 E7-expressing cells upon growth factor depriva-
tion but steady state levels are unaltered upon serum
deprivation, we next investigated whether the ability of
p53 to interact with a DNA consensus binding sequence
was altered upon growth factor deprivation extracts from
control and HPV-16 E7-expressing IMR-90 populations
grown in the presence and absence of fetal bovine serum
were used for electrophoretic mobility shift assay
(EMSA) analysis (Fig. 1D). Raji cell lysates were used
as positive control. A p53-specific antibody was added in
some lanes to establish the specificity of the band shift
and because it has been noted that it stabilizes p53 in its
DNA binding conformation (Hupp et al., 1992). This
experiment showed that the stabilized p53 in proliferating
HPV-16 E7-expressing cells is capable of binding to its
target DNA site even though it is not transcriptionally
active (Eichten et al., 2002). No increase in the DNA
binding capacity of p53 was observed upon growth factor
deprivation in control or HPV-16 E7-expressing IMR-90
cells (Fig. 1D). This indicates that the intrinsic capacity
of p53 to interact with its DNA target sequence is not
altered in apoptotic versus proliferating HPV-16 E7-
expressing cells.Fig. 2. (A) Expression analysis of a set of p53 target genes using a ‘‘human apopt
from control (LXSN) and HPV-16 E7-expressing (E7) IMR-90 cells grown in th
signals did not show any significance (>twofold) with any of these genes. Similar r
analysis of the p53 responsive apoptosis regulatory gene Noxa in control (LXSN)
presence (10%) of fetal bovine serum (FBS). GAPDH expression is shown as a
analysis in the different IMR-90 populations in the absence (0%) and presence (10
control.No evidence for increased expression of p53-dependent
transcriptional target genes in response to serum depriva-
tion of HPV-16 E7-expressing cells
The transcriptional activity of p53 is elevated in many
apoptotic settings, and several p53 responsive genes directly
contribute to the apoptotic response (reviewed in Vousden
and Lu, 2002). To investigate whether p53 may be rendered
transcriptionally active during serum deprivation mediated
apoptosis in HPV-16 E7-expressing cells, an ‘‘Atlas Apo-
ptosis’’ cDNA array that contains 12 known p53 target genes
was hybridized with probes generated from mRNAs isolated
from control and HPV-16 E7-expressing cells in the presence
and absence of growth factors. Although the basal expres-
sion level of the p53 responsive genes varied in the different
cell populations, none of these 12 genes were expressed at a
significantly higher level in growth factor deprived HPV-16
E7-expressing cells (Fig. 2A). This suggests that p53 is not
generally activated as a transcription factor in serum-de-
prived HPV-16 E7-expressing IMR-90 cells.
Northern blot analyses of additional putative p53 target
genes revealed a slight increase in the mRNA levels of
Noxa, a BH3 domain only pro-apoptotic Bcl-2 family
member that interacts with anti-apoptotic Bcl-2 family
members at the mitochondria (Oda et al., 2000a) (Fig.
2B). Analysis of Noxa by immunoblot revealed increased
protein levels in HPV-16 E7-expressing IMR-90 cells, and
an additional increase was observed upon serum starvation
(Fig. 2C). Noxa levels in proliferating HPV-16 E7-express-
ing cells were similar to those in E6 or p53DD expressing
IMR-90 cells, suggesting that increased Noxa mRNA levels
in HPV-16 E7-expressing cells are not related to p53 activity
(Fig. 2C).
y 319 (2004) 81–93osis Atlas cDNA array’’ with cDNA probes prepared from mRNAs derived
e presence (10%) or absence (0%) fetal bovine serum. Quantitation of the
esults were obtained in multiple independent experiments. (B) Northern blot
and HPV-16 E7-expressing (E7) IMR-90 cells grown in the absence (0%) or
loading control. (C) Expression analysis of Noxa protein by immunoblot
%) of fetal bovine serum (FBS). GAPDH expression is shown as a loading
irology 319 (2004) 81–93 85Induction of IGFBP-2 and -5 expression in HPV-16 E7-
expressing IMR-90 cells in response to serum deprivation
The cDNA array that we analyzed also contained several
genes that are not regulated by p53. Among these, we
detected significant up-regulation of insulin-like growth
factor binding protein (IGFBP)-2 and IGFBP-5, but not of
any of the other IGFBPs at the mRNA level (Fig. 3A, left
panels). Analysis of protein levels by immunoblot similarly
documented increased expression of IGFBP-2 and IGFBP-5
specifically in HPV-16 E7-expressing IMR-90 cells sub-
jected to serum deprivation (Fig. 3A, right panels). This
A. Eichten et al. / VFig. 3. (A) Expression analysis of IGFBPs at the mRNA level (left set of panels) an
expressing (E7) cell populations in the presence (10%) or absence (0%) of fetal bo
obtained in multiple independent experiments. (B) Immunoblot analysis of p53, IG
or absence (0%) of fetal bovine serum (FBS). GAPDH expression is shown as a loa
in Fig. 2C, and the p53 and GAPDH panels are thus identical. (C) Immunoblot a
(LXSN) and HPV-16 E7-expressing (E7) IMR-90 cells in the presence (10%) and a
IGFBP-2 is shown as a positive control and GAPDH expression as a loading co
expressing IMR-90 cells in response to serum starvation. Apoptosis was determin
HPV-16 E7-expressing IMR-90 cells grown in the absence of fetal bovine serum
(black bars). (E) NF-nB DNA binding activity in the different cell populations grow
by EMSA. The band denoted ‘‘NF-nB’’ may represent p50/p65 heterodimers as de
bands denoted by stars may represent p50 (lower) and p65 homodimers (upper), re
90 cells by transient expression of a dominant negative InB mutant results in decre
the parental plasmid pcDNA3. Expression of co-transfected green fluorescent prot
are shown as a loading control.analysis included IGFBP-1 that was not spotted on the
cDNA array.
As secreted proteins, IGFBPs can bind insulin-like
growth factor-1 (IGF-1) and positively or negatively mod-
ulate the cellular availability of this important cellular
survival factor. IGFBP-3 is a transcriptional p53 target
(Buckbinder et al., 1995) and its expression in HPV-16
E7-expressing cells undergoing apoptosis remained un-
changed (Figs. 2A and 3A). Our immunoblot experiments
only included determination of intracellular IGFBP expres-
sion, as we were unable to analyze levels of secreted
IGFBPs (data not shown).d at the protein level (right set of panels) in control (LXSN) or HPV-16 E7-
vine serum (FBS). Quantitations are shown underneath. Similar results were
FBP-2, and IGFBP-5 in the different cell populations in the presence (10%)
ding control. The results were generated as part of the experiment displayed
nalysis of AKT phosphorylation at serine 473 and threonine 308 in control
bsence (0%) of fetal bovine serum (FBS) using phospho-specific antibodies.
ntrol. (D) Exogenously added IGF-1 can inhibit apoptosis in HPV-16 E7-
ed by fluorescence analysis of Hoechst stained nuclei at each time point in
(open bars) or in serum-free medium supplemented with 100 ng/ml IGF-1
n in the presence (+) or absence () of 10% fetal bovine serum determined
termined by supershift experiments using the corresponding antibodies. The
spectively. (F) Inhibition of NF-nB activity in HPV-16 E7-expressing IMR-
ased IGFBP-2 and IGFBP-5 expression. Control cells were transfected with
ein (GFP) is shown to document similar transfection efficiencies; InB levels
Fig. 4. Enzymatic activities of caspase 3 (A) and caspase 8 (B) in control
(LXSN) and HPV-16 E7-expressing (E7) IMR-90 in the presence (open
bars) or absence (black bars) of fetal bovine serum using specific
fluorogenic substrates. Results are expressed as relative fluorescence units
(RFU). Control IMR-90 cells treated with TNF-a (hatched bars) were used
as positive controls. Similar results were obtained in multiple independent
experiments. (C) Microscopic determination of cell morphologies of control
(LXSN) or HPV-16 E7-expressing (E7) IMR-90 cells in the presence (10%)
or absence (0%) of fetal bovine serum in the absence (C) or presence of the
general caspase inhibitor zVAD-fmk (zVAD). (D) Nucleosomal DNA
fragmentation in control (LXSN) or HPV-16 E7-expressing (E7) IMR-90
cells in the presence or absence of serum and the general caspase inhibitor
zVAD-fmk as determined by an ELISA-based quantitative DNA laddering
assay. Results from single representative experiments are shown; similar
results were obtained in multiple independent experiments.
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E7-expressing cells that also expressed E6 or the dominant
negative p53DD mutant revealed that the enhanced expres-
sion of these proteins relative to control cells is not correlated
to p53 activity but that the additional increase of expression
upon serum deprivation was only observed in HPV-16 E7-
expressing cells that undergo apoptosis (Fig. 3B). IGFBP-2
and IGFBP-5 expression is not a general response to apo-
ptosis however, as IGFBP-2 and IGFBP-5 levels did not
markedly increase when HPV-16 E7-expressing cells were
triggered to undergo apoptosis in response to other stimuli
such as actinomycin D, cisplatin, doxorubicin, or etoposide.
Of note, however, in each case, HPV-16 E7-expressing cells
underwent apoptosis at increased rates compared to similarly
treated control IMR-90 cells (data not shown).
Given the potential importance of IGFBPs in IGF-1
survival signaling, we next determined the phosphorylation
status of the kinase AKT that is an important downstream
modulator of the IGF-1 pathway. Using antibodies specific
for AKT phosphorylated at serine residue 473 or threonine
308, we detected decreased phosphorylation at these resi-
dues in serum-deprived HPV-16 E7-expressing cells as
would be expected in cells that lack survival signals. In
contrast, no AKT dephosphorylation was detected in serum-
starved control IMR-90 cultures that undergo growth arrest
(Fig. 3C).
To determine whether IGF-1 can act as a survival factor
for serum-deprived HPV-16 E7-expressing IMR-90 cells,
we added IGF-1 to the culture medium. As illustrated in Fig.
3D, exogenously added IGF-1 could inhibit but not abrogate
the trophic sentinel response in HPV-16 E7-expressing
fibroblasts.
These results are consistent with a model that up-regu-
lation of IGFBP-2 and -5 contribute to the apoptotic
response of HPV-16 E7-expressing fibroblasts by restricting
IGF-1 availability.
EMSA experiments revealed evidence for increased NF-
nB activity in HPV-16 E7-expressing IMR-90 cells partic-
ularly under conditions of serum deprivation (Fig. 3E). This
increase was independent of p53 activity as it was also
observed in cells that expressed HPV-16 E7 in combination
with E6 or the dominant negative p53DD mutant even when
the cells were supplied with 10% serum (Fig. 3E). NF-nB
activity is controlled by nuclear translocation through the
cytoplasmic inhibitor molecule InB. Upon activation, InB is
phosphorylated at amino terminal residues and rapidly
degraded thus allowing for nuclear translocation and NF-
nB activation. Expression of a non-phosphorylatable, non-
degradable dominant negative DN-InB mutant that lacks the
amino terminal domain can abrogate NF-nB activation.
When we transiently expressed this mutant in HPV-16 E7-
expressing cells, we detected a marked decrease in IGFBP-2
and IGFBP-5 levels (Fig. 3F). These results suggest that the
high-level expression of these two IGFBPs in serum-starved
HPV-16 E7-expressing cells may at least in part be a
consequence of increased NF-nB activity. IGFBP-2 isknown to contain an NF-nB site in its regulatory domain
(Cazals et al., 1999).
Activation of caspase 3 but not caspase 8 in HPV-16 E7-
expressing cells upon growth factor withdrawal
Apoptosis can be signaled through two different major
pathways, both of which converge on the activation of
caspase 3. One pathway involves death domain receptors
that mediate caspase 8 cleavage and activation, which then
triggers a caspase cascade. In contrast, apoptosis induced by
DNA damage or growth factor deprivation is not mediated
by activation of caspase 8. The trophic sentinel pathway
triggered by the c-myc and adenovirus E1A oncogenes each
results in caspase 8 activation (Hueber et al., 1997; Nguyen
et al., 1998). Hence, we analyzed activity levels of caspase
8 and caspase 3 in control and HPV-16 E7-expressing IMR-
90 populations in the presence and absence of growth
factors. IMR-90 cells treated with tumor necrosis factor a
(TNF-a) and cycloheximide served as a positive control for
activation of caspase 8 and caspase 3. These experiments
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deprived HPV-16 E7-expressing cells (Fig. 4A), whereas no
activation of caspase 8 activity was observed (Fig. 4B).
This result indicates that in contrast to c-myc or E1A, the
trophic sentinel response of HPV-16 E7-expressing cells
results in caspase 3 activation through a caspase 8-indepen-
dent mechanism.
A general caspase inhibitor does not prevent cell death but
abrogates nucleosomal DNA fragmentation
Next we investigated whether inhibition of caspase
activation by a general caspase inhibitor could inhibit cellFig. 5. (A) Enzymatic activity of caspase 2 in control (LXSN) and HPV-16 E7-ex
bars) of fetal bovine serum. Analysis of nucleosomal DNA fragmentation (B) an
bovine serum and the caspase-2-specific inhibitor zVDVAD-fmk. The results show
should be compared to the controls shown there. Similar results were obtained in
subcellular localization of cytochrome c in HPV-16 E7-expressing IMR-90 cells in
or presence of the general caspase inhibitor zVAD-fmk (zVAD). Nuclei were coun
taxol or left untreated (C) are shown as a positive control for cytochrome releasedeath in HPV-16 E7-expressing cells induced by serum
deprivation. Surprisingly, treatment of HPV-16 E7-express-
ing cells with the cell permeable general caspase inhibitor
zVAD-fmk did not interfere with the induction of cell
death in response to serum deprivation (Fig. 4C). Control
experiments showed that this inhibitor was indeed able to
inhibit caspase 3 activity (data not shown). Moreover,
analysis of DNA fragmentation by an ELISA-based assay
revealed that caspase inhibition by zVAD-fmk interfered
with DNA fragmentation (Fig. 4D). This result strongly
suggests that caspase-independent mechanisms of cell
death contribute to the trophic sentinel response of HPV-
16 E7-expressing cells.pressing (E7) IMR-90 cells in the presence (open bars) and absence (black
d cellular morphology (C) in the absence (0%) or presence (10%) of fetal
n in panel C were generated as part of the experiment shown in Fig. 4C and
multiple independent experiments. (D) Immunofluorescence analysis of the
the presence (10%) or absence (0%) of fetal bovine serum in the absence (C)
terstained with Hoechst dye. MCF-7 human breast cancer cells treated with
to the cytoplasm.
rology 319 (2004) 81–93Caspase 2 activation and cytochrome c release do not
contribute to cell death signaling in HPV-16 E7-expressing
cells in response to growth factor deprivation
It has been postulated that mitochondrial dysfunction is
involved in triggering apoptosis in response to growth
factor deprivation, and the finding that the pro-apoptotic
Bcl-2 family member Noxa was expressed at higher levels
in growth factor deprived HPV-16 E7-expressing cells
(Figs. 2B, C) led us to investigate a potential mitochondrial
involvement in greater detail. A recent report has indicated
that caspase 2 activation occurs early before mitochondrial
permeabilization during stress-induced apoptosis (Lassus et
al., 2002). Activity assays using a caspase 2-specific
substrate however did not yield any evidence for caspase
2 activation (Fig. 5A), and inhibition of caspase 2 activity
by the specific inhibitor zVDVAD-fmk did not affect
nuclear fragmentation (Fig. 5B) or cell death (Fig. 5C).
To investigate whether mitochondrial integrity may be
compromised in serum-deprived HPV-16 E7-expressing
cells, we analyzed cytochrome c release by immunofluo-
rescence analysis and by ELISA assay. Taxol-treated MCF-
7 breast cancer cell lines were used as a positive control.
Even HPV-16 E7-expressing cells with abnormally con-
densed nuclei showed no evidence for cytochrome c
release, regardless whether caspases were inhibited or not
(Fig. 5D and data not shown). Hence, it is unlikely that
caspase dependent or independent forms of cell death of
serum-deprived HPV-16 E7-expressing cells are a conse-
quence of mitochondrial dysfunction.
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HPV-16 E7 oncoprotein-expressing diploid human fibro-
blasts are predisposed to apoptosis upon suboptimal growth
conditions (Jones et al., 1997; White et al., 1994). This
likely represents a consequence of ‘‘opposing growth sig-
nals’’ where cells have acquired a constitutive nuclear
growth-promoting signal due to an oncogenic stimulus
and thus maintain proliferative activity irrespective of the
lack of extracellular growth signals. Hence, this trophic
sentinel response represents an important cellular defense
mechanism to eliminate abnormal cells that may be predis-
posed to undergo malignant progression (reviewed in Evan
and Vousden, 2001). This paradigm was initially established
through studies on the adenovirus E1A (Rao et al., 1992;
White et al., 1992) and c-myc (Evan et al., 1992) oncopro-
teins. In addition, many viruses that as part of their repli-
cation strategy inactivate pRb also encode a second
cooperating activity to target p53, and that tumors with
pRb tumor suppressor pathway aberrations generally also
had suffered some mutation in the p53 tumor suppressor
pathway (reviewed by Weinberg, 1997). Thus, the model
emerged that p53 may be the ‘‘guardian of pRb’’ (White,
1994). The finding that p14ARF, an inhibitor of mdm2-mediated p53 degradation (Stott et al., 1998; Zhang et al.,
1998), was a transcriptional target of E2F provided the
apparent mechanistic vindication for this model (Bates et al.,
1998).
We have shown previously that the cytotoxic activity of
the HPV-16 E7 oncoprotein correlated with pRb degradation
and p53 stabilization (Jones et al., 1997). Importantly,
however, stabilized p53 in HPV-16 E7-expressing cells
was not fully active transcriptionally (Eichten et al.,
2002). Whereas acute HPV-16 E7 expression causes pRb
degradation (Berezutskaya et al., 1997; Gonzalez et al.,
2001), increased p14ARF expression and p53 stabilization
are not observed in similar transient transfection experi-
ments (Eichten et al., 2002; A. Eichten and K. Mu¨nger,
unpublished observations). Moreover, the ability of HPV-16
E7 to stabilize p53 is independent of the cellular ARF status
(Seavey et al., 1999). Previous studies also showed that co-
expression of E6 that targets p53 for rapid proteasomal
degradation abrogated the cytotoxic activity of the HPV E7
oncoprotein in primary human fibroblasts (Jones et al.,
1997). Here we demonstrate that a dominant negative p53
mutant abrogates the trophic sentinel response in HPV-16
E7-expressing cells triggered in response to growth factor
deprivation (Fig. 1A), thus providing additional evidence
for the involvement of p53 in this process. This is similar to
the situation with the adenovirus E1A protein, where the
apoptotic response was shown to be p53 dependent and is
balanced by E1B that binds p53 (Debbas and White, 1993).
The data on p53-dependence of c-myc-induced apoptosis are
somewhat more confusing (Hermeking and Eick, 1994; Hsu
et al., 1995), and both p53-dependent and -independent
pathways have been implicated (Sakamuro et al., 1995).
Of note, however, and in contrast to what we observed here,
expression of dominant negative p53 did not abrogate the
trophic sentinel response in c-myc expressing fibroblasts
(Juin et al., 1999).
The p53 homologues p63 and p73 are required for p53-
dependent apoptosis in response to DNA damage (Flores et
al., 2002). Some dominant negative p53 mutants can also
interact with p63 and p73 (reviewed in Moll et al., 2001). It
is therefore possible that p63 or p73 functions may be
altered by the dominant negative mutant p53 used here,
and may contribute to the cell death response of HPV-16
E7-expressing fibroblasts to growth factor deprivation.
Serum deprivation of HPV-16 E7-expressing IMR-90
cells did not cause marked alterations in phosphorylation at
any of the sites of p53 that were investigated (Fig. 1C), and
the capacity of p53 to interact with a consensus DNA
binding sequence remained unaltered (Fig. 1D). In addition,
several common transcriptional targets of p53 were not
affected (Fig. 2A). We realize the limitations of these experi-
ments, and a chromatin immunoprecipitation survey (‘‘CHIP
on CHIP’’) analysis will have to be performed to explore this
issue in greater detail. We did, however, evaluate additional
p53 targets that have been implicated in apoptosis including
PUMA (Nakano and Vousden, 2001; Yu et al., 2001) and
A. Eichten et al. / Virology 319 (2004) 81–93 89Noxa (Oda et al., 2000a; Shibue et al., 2003) (Fig. 2B and
data not shown). Noxa was expressed at somewhat higher
levels in HPV-16 E7-expressing cells undergoing apoptosis.
The increase of Noxa mRNAwas much more modest than at
the protein level (Figs. 2B, C), and furthermore, increased
Noxa levels were also observed in HPV-16 E7 cells that co-
expressed the dominant negative p53 mutant (Fig. 2C). Thus,
it is unlikely that the observed induction of Noxa expression
in HPV-16 E7-expressing cells is p53 dependent (Fig. 2C).
Moreover, given that there was no evidence for cytochrome c
release and thus mitochondrial dysfunction (Fig. 5), the
relevance of increased Noxa expression for triggering the
trophic sentinel response in serum-deprived HPV-16 E7-
expressing fibroblasts is doubtful.
We did, however, observe increased expression of two
IGF-1 binding proteins, IGFBP-2 and IGFBP-5, in HPV-16
E7-expressing fibroblasts, and expression was further in-
creased when such cells were deprived of growth factors
(Fig. 3A). IGFBPs are secreted proteins that modulate the
cellular availability of IGF-1 thereby affecting cellular
survival. In addition, nuclear IGFBP populations have also
been detected and it is thus conceivable that IGFBPs have
biological activities in addition to IGF-1 binding (reviewed
in Firth and Baxter, 2002; LeRoith and Roberts, 2003).
IGFBP-3 (which was not expressed at increased levels in
our experiments, Fig. 3A) is a transcriptional target of p53
with relevance to apoptosis (Buckbinder et al., 1995). HPV-
16 E7 has been reported to bind and target IGFBP-3 for
degradation (Mannhardt et al., 2000), but IGFBP-3 levels in
HPV-16 E7-expressing cells were similar to control cells in
our experiments (Fig. 3A). Less is known concerning
IGFBP-2 and IGFBP-5. IGFBP-2 is frequently overex-
pressed in hormone-independent prostate cancer where it
enhances cell division and prevents apoptosis (Kiyama et
al., 2003). Nuclear IGFBP-2 has been detected upon oxida-
tive stress (Firth and Baxter, 2002). Similar to IGFBP-2,
IGFBP-5 scores as a survival factor in androgen-indepen-
dent prostate cancer cells (Miyake et al., 2000) but has a
strong pro-apoptotic activity in mammary epithelial cells
both by sequestration of IGF-1 and through direct intracel-
lular mechanisms (Butt et al., 2003; Marshman et al., 2003;
McCaig et al., 2002; Tonner et al., 2000, 2002). Consistent
with the notion that increased IGFBP-2 and IGFBP-5
expression in HPV-16 E7-expressing cells may interfere
with IGF-1 survival signaling, phosphorylation of the im-
portant downstream mediator AKT (reviewed in Datta et al.,
1999) was decreased in serum-deprived HPV-16 E7-
expressing cells. No AKT dephosphorylation was observed
in serum-starved control cells (Fig. 3C). Time course experi-
ments revealed that upon serum deprivation of HPV-16 E7-
expressing cells, levels of two IGFBPs increased in parallel
with the cell death response (data not shown). Similar to c-
myc (Hueber et al., 1997; Juin et al., 1999), IGF-1 inhibited
the apoptotic response of serum-deprived HPV-16 E7-
expressing cells (Fig. 3D). Upregulation of IGFBP-2 and
IGFBP-5 is independent of the p53 status of the cell (Fig.3B) but may be related to the increases in NF-nB activity
detected in HPV-16 E7-expressing cells upon serum starva-
tion. In most scenarios, NF-nB activation represents a
survival response that can balance pro-apoptotic stimuli,
for example, those transmitted by engaging death-domain
receptors (Antwerp et al., 1996), or by expression of the ras
oncoprotein (Mayo et al., 1997). On the other hand, NF-nB
activity is necessary for the pro-apoptotic activity of p53
(Ryan et al., 2000) and E2F-1 (Phillips et al., 1999).
Unfortunately, however, expression of the dominant nega-
tive DN-InB mutant interfered with the viability of IMR-90
cells regardless of whether HPV-16 E7 was expressed or
not, and our attempts to directly test whether increased NF-
nB activity represented a pro-apoptotic or anti-apoptotic
stimulus were futile.
The trophic sentinel response to the c-myc oncoprotein
may be dependent on death domain receptor signaling
(Hueber et al., 1997), even though this model has subse-
quently been challenged (Juin et al., 1999; Yeh et al., 1998).
Similarly, the adenovirus E1A protein can induce pro-
caspase 8 processing and activation when the trophic
sentinel response is engaged, although this likely occurs
independently of death domain signaling (Nguyen et al.,
1998). In contrast, there was no evidence for caspase
8 activation upon serum starvation of HPV-16 E7-express-
ing cells (Fig. 4B). This is consistent with an earlier study
from our lab that documented decreased caspase 8 activation
in these HPV-16 E7-expressing IMR-90 cells in response to
TNF-a/cycloheximide treatment (Thompson et al., 2001).
We did, however, detect activation of the executioner
caspase 3 (Fig. 4A).
Generic caspase inhibition does not reduce cell death
(Fig. 4C) even though nuclear DNA fragmentation is
inhibited (Fig. 4D). This result was not unexpected because
similar to what we observed here, treatment of c-myc
expressing cells with the general caspase inhibitor zVAD
also abrogated nuclear DNA fragmentation but was unable
to inhibit cell death per se (McCarthy et al., 1997). In
contrast, zVAD inhibits E1A-induced apoptosis (Putzer et
al., 2000).
The ‘‘point of no return’’ in induction of cell death is
usually characterized by mitochondrial dysfunction
(reviewed in Blackstone and Green, 1999). The mitochon-
dria serve an important role in signal integration and
amplification during apoptosis, particularly in cases where
the cell death program is triggered by factors other than
death domain receptors (reviewed by Green and Kroemer,
1998). Caspase 2 activation precedes this and is necessary
for mitochondrial permeabilization in response to cytotoxic
stress (Lassus et al., 2002). Similar to the c-myc oncogene
(Vafa et al., 2002), HPV-16 E7 causes DNA breaks (Duens-
ing and Mu¨nger, 2002), and we investigated whether
caspase 2 may be activated and transmit a DNA damage-
related apoptotic response to mitochondria. However, no
evidence for caspase 2 activation was observed in serum-
starved HPV-16 E7-expressing cells (Fig. 5A), and a cas-
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DNA fragmentation (Figs. 5B, C). In response to some
apoptotic stimuli, p53 can translocate to the mitochondria
(Marchenko et al., 2000). Analysis of p53 subcellular
localization in serum-deprived HPV-16 E7-expressing
IMR-90 cells, however, demonstrated that p53 remained
nuclear with no apparent mitochondrial relocalization (data
not shown).
Nevertheless, it was unexpected that immunofluores-
cence (Fig. 5D) or ELISA (data not shown) experiments
did not yield any evidence for cytochrome c release and thus
mitochondrial permeabilization in serum-starved HPV-16
E7-expressing cells. The trophic sentinel response of c-
myc and adenovirus E1A-expressing cells is each associated
with cytochrome c-release (Juin et al., 1999; Nguyen et al.,
1998) and is clearly modulated at the level of the mitochon-
dria (Bissonnette et al., 1992; Debbas and White, 1993;
Fanidi et al., 1992; Rao et al., 1992). Cytochrome c release
is necessary for the formation of the apoptosome that
triggers cleavage and activation of pro-caspases 9 and 3
(Li et al., 1997). Mitochondrial dysfunction is also a
hallmark of caspase-independent cell death and is also
mediated by release of mitochondrial proteins such as
apoptosis-inducing factor (AIF) (Susin et al., 1999). Anal-
ysis of AIF by immunofluorescence in our system did not
yield any evidence for nuclear translocation (data not
shown). Clearly, additional studies will be necessary to
further analyze the potential mitochondrial involvement in
mediating the cell death response in serum-starved HPV-16
E7-expressing fibroblasts.
The fact that the functionally related nuclear oncogenes
c-myc, adenovirus E1A, and HPV-16 E7 each predispose
primary human cells to apoptosis clearly illustrates the
importance of this cellular surveillance mechanism in elim-
inating aberrantly proliferating cells. It appears that expres-
sion of HPV-16 E7, adenovirus E1A, and c-myc triggers
apoptosis through different pathways, but such comparisons
are complicated by the fact that different groups use
different cell systems for their experiments.
The majority of human solid tumors are derived from
epithelial cells, and squamous epithelial cells are also the
normal hosts of HPVs. In a transgenic mouse model,
targeted expression of HPV-16 E7 to lens epithelial cells
causes apoptosis. Similar to the fibroblast system used here,
cell death is ablated by co-expression of E6 (Pan and Griep,
1994) and is at least in part p53 dependent (Pan and Griep,
1995). Thus far, we were unsuccessful in identifying growth
factor conditions that stimulate apoptosis specifically in
HPV-16 E7-expressing primary human foreskin keratino-
cytes even though E7-expressing keratinocytes are sensi-
tized to apoptosis in response to other stimuli (Stoppler et
al., 1998). The majority of human squamous epithelial cells
that can be established in culture may be proliferating cells
that are intrinsically primed to undergo squamous differen-
tiation. The differentiation process of squamous epithelia is
quite unique in that the terminally differentiated cells arephysically shed from the organism. Oncogenic insults in
epithelial cells that are intrinsically committed to squamous
differentiation may be physiologically less consequential
than in other cell types, and elimination of differentiating
squamous epithelial cells through apoptosis might also
interfere with the mechanical stability of the skin. Hence,
such cells may not be programmed to committing suicide in
response to opposing growth signals.
In order to achieve long-term persistent infection of their
hosts, HPVs may infect less committed basal epithelial cells
such as reserve cells. Squamous epithelial differentiation is
not their default program and such cells may only be
triggered to divide infrequently and in response to very
specific instruction sets such as hormonal or regenerative
processes. It is conceivable that in such cells, similar to
murine lens epithelial cells, the trophic sentinel response to
HPV E7 oncogene expression may be more vigilantly
enforced and lead to apoptosis.Materials and methods
Cell culture, cell lines, transfections, retrovirus production,
and infections
Low passage normal human diploid lung fibroblasts
(IMR-90), telomerase-immortalized (hTERT) IMR-90 cells
(obtained from Sheila Steward, Weinberg laboratory, White-
head Institute, MIT, Boston), the breast cancer cell line
MCF-7, and the African green monkey kidney cells COS-7
were maintained in Dulbecco’s modified Eagle’s Medium
(DMEM) supplemented with 10% fetal bovine serum
(FBS), 50 U/ml penicillin, and 50 Ag/ml streptomycin.
IMR-90 cells were transiently transfected with dominant
negative InB mutant lacking the amino terminus (generously
provided by M. Hinz, MDC Berlin-Buch, Germany) (Hinz et
al., 1999) or the parental plasmid pcDNA3 by nucleofection
using a commercially available apparatus and transfection kit
(Amaxa). A green fluorescent protein (GFP) expression
plasmid was co-transfected (1:10) to monitor transfection
efficiency. Production of recombinant retroviruses and ret-
roviral infections were performed as described previously
(Piboonniyom et al., 2003; Thompson et al., 1997).
Drug treatments
Cells were treated with 10 ng/ml TNF-a (R and D
Systems) and 30 Ag/ml cycloheximide (Sigma) for 7 h as
described previously (Thompson et al., 2001). IGF-1 (long
R3 IGF-1 recombinant analog, Sigma) dissolved at 1 mg/ml
in 10 mM HCl was used at a final concentration of 100 ng/
ml. UV treatment was performed by exposing cells to 50
mJ/m2 in a Stratalinker (Stratagene) followed by a 3-
h incubation in DMEM + 10% FBS. Taxol (paclitaxel)
(Sigma) was used at 100 nM for 24 h followed by incuba-
tion with fresh serum-free DMEM for another 48 h. Acti-
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(Sigma) was used at 10 Ag/ml, treatments with doxorubicin
(Sigma) and etoposide (Sigma) were at 200 ng/ml and 50
mM, respectively. The general caspase inhibitor zVAD-fmk
(Enzyme Systems Products) and the caspase 2 inhibitor
zVDVAD-fmk (Enzyme Systems Products) were dissolved
in DMSO at 20 and 10 mM, respectively, and used at a final
concentration of 20 AM. Inhibitors were replenished every
24 h during the experiments. Cells treated with the
corresponding amounts of DMSO were used as controls.
RNA isolation, cDNA arrays, and Northern blotting
A human apoptosis ATLAS cDNA array (Clontech) was
probed with single-stranded cDNA probes derived from
mRNA isolated from the different cell populations as
described previously (Eichten et al., 2002). Northern blot
analyses were performed with 10 Ag total RNA as described
previously (Eichten et al., 2002). A STORM PhosphoIm-
ager using ImageQuant software was used for quantitative
analyses.
Immunological methods
Immunoblot analyses were performed as described pre-
viously (Eichten et al., 2002). The following antibodies
were used according to the recommendations of their
suppliers: p53 (Ab-6, Calbiochem), p21CIP1 (Ab-1, Onco-
gene Science), Noxa (Pharmingen), GAPDH (CHEMI-
CON), HPV-16 E7 (mixture of 8C9, 1:100, Zymed and
ED17, 1:1000, Santa Cruz), InB (Rabbit polyclonal, Santa
Cruz), IGFBP-1, 2,3,4,5,6 (goat polyclonal, Santa Cruz),
p50 (Rockland), p65 (Santa Cruz). Antibodies specific for
p53 phosphorylated at Ser6, Ser9, Ser15 Ser20, Ser37, and
AKT phosphorylated at serine 473 and threonine 308, were
purchased from Cell Signaling Technology; the p53 phos-
pho-serine 46 specific antibody (Oda et al., 2000b) was used
at a dilution of 1:1000 and was a gracious gift from Y. Taya,
Tokyo, Japan.
For immunofluorescence analyses, cells were fixed and
permeabilized in 4% paraformaldehyde/0.2% Triton X-100
for 20 min at 20 jC, washed in PBS, and incubated in 2.5%
donkey serum in PBS for 1 h at 20 jC, washed with PBS,
incubated with cytochrome c antibody (Pharmingen, 1:50)
for 1 h at 20 jC, washed twice in PBS followed by an
incubation with a Rhodamine Red-coupled secondary don-
key anti-mouse antibody (1:200) for 1 h at 20 jC. Nuclei
were counterstained with Hoechst dye.
Electrophoretic mobility shift assays
NF-nB electrophoretic mobility shift assay (EMSA)
analyses were performed as described previously (Basile
et al., 2003). Briefly, cells were lysed in EBL buffer (20 mM
HEPES/NaOH, pH 7.9, 350 mM NaCl, 20% glycerol, 1 mM
MgCl2, 0.5 mM EDTA, 0.1 mM EGTA, 1% NP-40, 0.1 mMNaO3VO4, 1 mM DTT, 0.57 mM PMSF, 1 Ag/ml leupeptin,
1 Ag/ml aprotinin, 1 mM NaF, 10 mM h-glycerophosphate)
for 30 min at 4 jC. Lysates were cleared at 16000  g for
10 min at 4 jC and DNA binding assays were performed
with 5 Ag of protein lysate in DNA binding buffer (40 mM
HEPES/NaOH, pH 7.9, 120 mM KCl, 8% Ficoll, 0.5 mM
DTT, 0.1 mg/ml BSA, 0.1 Ag/Al poly dIdC, 0.1% NP40) for
30 min at 30 jC.
Lysates for p53 EMSA were prepared by incubation of
cells in p53 EMSA lysis buffer (100 mM Tris–HCl, pH 8.0,
100 mM NaCl, 1% NP-40, 1 mM EDTA, 0.57 mM PMSF, 1
Ag/ml leupeptin, 1 Ag/ml aprotinin) for 30 min at 4 jC and
cleared by centrifugation at 16000  g for 5 min at 4 jC.
EMSA was performed using the p53 NUSHIFT kit (GEN-
EKA) according to the manufacturer’s instructions. Twenty
micrograms of protein lysate was used per reaction.
Complexes were separated on a 4% acrylamide gel and
vacuum-dried gels were exposed to X-ray film.
Caspase activity, apoptosis, and DNA fragmentation assays
Caspase activity assays (Clontech, ApoAlert Caspase 3
and 8 Fluorometric Assay Kit and R&D Systems, Caspase-2
Fluorometric Assay) were carried out according to manu-
facturers instructions. Lysates prepared from 1  106 cells
were used for the caspases 3 and 8 activity assays and 2 
106 cells for the caspase 2 activity assay.
For evaluation of apoptosis, cells were fixed within
methanol vapors and stained with 1 mg/ml of bisbenzimide
(Sigma, Hoechst 33258), and apoptosis was evaluated based
on nuclear condensation by fluorescence microscopy as
previously described (Jones et al., 1997).
Nucleosomal DNA fragmentation was quantified using
an ELISA-based DNA laddering assay (Cell Death Detec-
tion ELISA plus system) according to the manufacturer’s
instructions (Roche). Cells (104) were used for each assay
and experiments were performed in triplicate.Acknowledgments
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